dolcanatide

Cantor Fitzgerald initiated coverage of Synergy Pharmaceuticals Inc (NASDAQ: SGYP) at Overweight with a price target of $11. Analyst William Tanner estimates second quarter earnings of $1.4 million with a negative $0.25 EPS. Fiscal 2017 earnings are estimated to be $11.3 million. Opportunities In...